clinical trial

A car's speedometer shows the speed right now, but to know whether the car will reach its destination in a year, a single glance at the gauge isn't enough. That's roughly how conventional formulas for kidney failure risk work: they rely on one blood test and miss how values have been shifting over months and years.

In boiling soup, molecules collide chaotically and react. But if you measure how their concentrations change, patterns emerge. This is how carbon chemical networks work — mixtures of molecules that spontaneously 'cook' information, turning each reaction into an elementary computation. Previously they were used only for modeling nature.

A doctor scrolls through a patient's chart and sees a line: "The drug reduces risk." But how much can you trust that? Is the claim based on a couple of case reports or on tens of thousands of patients in a blinded trial? The answer determines the treatment.

In a car, the steering, brakes, and accelerator gradually fail. At first, you can still swerve around a pothole, but each year the maneuver takes more effort. At some point, even a perfect road becomes impassable — the car no longer obeys the driver. That's exactly how the authors describe aging: not as the accumulation of rust or wear and tear, but as the loss of "controllability" of the body.

Silicon is like a universal building block: it goes into the chips in your phone, solar panels, and lasers. But if you squeeze it with immense force, the atoms rearrange into new patterns: these forms are called allotropes. One of them, Si-XIII, was first spotted more than twenty years ago, but its exact pattern remained a mystery.

Every breath in and out shifts internal organs by several centimeters. For an MRI scanner imaging the abdomen, this is like photographing a runner with a long exposure — the image comes out blurred. Clinicians have long known how to deal with this: they ask patients to hold their breath or take a series of fast snapshots between breaths. These methods are simple but effective.